• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORPORATION, TAKAHAGI PLANT GEL ONE 30/3 MG/ML - MILLLIGRAMS PER MILLILITRES; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORPORATION, TAKAHAGI PLANT GEL ONE 30/3 MG/ML - MILLLIGRAMS PER MILLILITRES; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Lot Number 0020D24G
Device Problem Insufficient Information (3190)
Patient Problem Insufficient Information (4580)
Event Date 09/29/2020
Event Type  Injury  
Event Description
Member's wife has reported the member is in hospice.Event ongoing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GEL ONE 30/3 MG/ML - MILLLIGRAMS PER MILLILITRES
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORPORATION, TAKAHAGI PLANT
MDR Report Key10627891
MDR Text Key209978389
Report NumberMW5097048
Device Sequence Number1
Product Code MOZ
UDI-Device Identifier87541030091
UDI-Public87541-0300-91
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date08/02/2022
Device Lot Number0020D24G
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age93 YR
-
-